|
|
Tikcro Technologies Ltd. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Tikcro Technologies Ltd.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Tikcro Technologies Ltd.. The Group is a development-stage company. The Group seeks to merge or effect a business combination with a domestic or foreign, private or public operating company or to acquire minority stakes in one or more operating companies in new areas of operations. In July 2008, the Group acquired minority stake in BioCancell Therapeutics, Inc. (BioCancell), an Israel-based clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The Group operates mainly in Israel.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|